Skip to content

Other assets at other companies

Alto Ingredients, Inc. logo
Alto Ingredients, Inc.ALTO
$6.46M+10.6%
OFL
Omega FlexOFLX
$1.81M-24.0%
M/I Homes logo
M/I HomesMHO
$369.72M+18.5%
EOG Resources logo
EOG ResourcesEOG
$562M-0.2%
NXP Semiconductors logo
NXP SemiconductorsNXPI
$644M+2.7%
State Street logo
State StreetSTT
$3.47B+22.9%

Other financials

Income statement

See full
Revenue$58.8M+10.3%
Gross profit$54.2M+10.8%
Operating income$11.9M-7.0%
Net income$8.7M-24.4%
EPS (diluted)$0.44-30.2%

Balance sheet

See full
Cash & equivalents$24.5M-46.6%
Total debt$68.4M+5,079%
Total equity$399.9M+2,054%
Total assets$504.6M+187%

Cash flow

See full
Operating cash flow$2.7M+405%
CapEx$73.0K
Free cash flow-$22.0M

Valuation

See full
Market cap$684.39M+102%
Enterprise value$728.29M+148%
P/E1.9×-7.2×
P/S2.3×+0.6×

Profitability

See full
Gross margin93.4%+3.7pp
Operating margin41.6%+19.9pp
Net margin121.5%+103pp
FCF margin-61.7%

Returns & leverage

See full
Return on equity174.1%
Debt / equity0.2×+0.1×
Current ratio2.6×+0.4×

Where this comes from

Reported directly by Rigel Pharmaceuticals in its filing.

Tagged under the XBRL concept rigl:InventoryReportedAsOtherAssets.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rigel Pharmaceuticals's other assets?
Rigel Pharmaceuticals (RIGL) reported other assets of $2.1M in Q1 2026.
What does other assets mean?
This represents inventory-related items that do not meet the standard criteria for classification as raw materials, work-in-progress, or finished goods. It often includes long-term inventory or specialized components held for future development cycles. Tracking this helps investors understand potential liquidity constraints tied to non-liquid inventory holdings.